The chemical class of PHTF2 activators encompasses a diverse array of compounds that can indirectly affect the activity of the PHTF2 transcription factor through various mechanisms. These compounds may influence PHTF2 by altering cellular signaling pathways, chromatin accessibility, or the phosphorylation state of proteins. For instance, molecules like forskolin can raise intracellular cAMP levels, indirectly modulating transcription factors by changing the phosphorylation status of proteins within the cell. Increased cAMP typically enhances the activity of protein kinase A (PKA), which can phosphorylate transcription factors, thereby altering their ability to regulate gene expression.
Another layer of regulation is provided by epigenetic modulators such as 5-Azacytidine and Trichostatin A. These agents can modify the epigenetic landscape by affecting DNA methylation and histone acetylation, respectively. By changing the epigenetic marks, these compounds can increase the transcription of genes, possibly including those under the control of PHTF2. Additionally, modulators of cellular signaling pathways like PMA can activate protein kinase C (PKC), potentially leading to altered phosphorylation and activity of transcription factors. Conversely, inhibitors of signaling kinases, such as SP600125 and SB203580, may lead to changes in transcription factor activities by modulating the activities of c-Jun N-terminal kinase (JNK) and p38 MAPK, respectively. These activities suggest that the modulation of kinase signaling can have downstream effects on transcription factors, including PHTF2.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Adenylyl cyclase activator that increases intracellular cAMP levels, potentially enhancing CREB phosphorylation and activity, which could upregulate the expression of a range of transcription factors including PHTF2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PKC activator that can modulate transcription factors by phosphorylation, which could alter PHTF2 activity if it is downstream of PKC signaling. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that reduces methylation, potentially leading to the upregulation of genes including those coding for transcription factors such as PHTF2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can result in a more relaxed chromatin structure, potentially increasing access to DNA for transcription factors like PHTF2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Involved in gene expression modulation via retinoic acid receptors, could upregulate transcription factors through retinoid signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK-3 inhibitor that may lead to the stabilization and activation of β-catenin, influencing the activity of TCF/LEF transcription factors which could interact with or modify the activity of PHTF2. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
HDAC inhibitor that can cause hyperacetylation of histones, potentially affecting the transcriptional regulation of numerous genes including those controlled by PHTF2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Sirtuin activator that influences chromatin structure and gene expression, potentially altering transcription factor activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor that can modulate AP-1 transcription factor activity, which may have downstream effects on other transcription factors. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor that could affect transcription factor regulation indirectly through the MAPK pathway. |